Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England

PURPOSE: To compare adherence to once-daily umeclidinium/vilanterol (UMEC/VI), a long-acting muscarinic antagonist/long-acting β(2)-agonist (LAMA/LABA), and twice-daily inhaled corticosteroids (ICS)/LABA single-inhaler dual therapy in patients with chronic obstructive pulmonary disease (COPD) in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Czira, Alexandrosz, Requena, Gema, Banks, Victoria, Wood, Robert, Tritton, Theo, Castillo, Catherine M, Yeap, Jie, Wild, Rosie, Compton, Chris, Rothnie, Kieran J, Herth, Felix, Quint, Jennifer K, Ismaila, Afisi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122847/
https://www.ncbi.nlm.nih.gov/pubmed/37155496
http://dx.doi.org/10.2147/COPD.S405498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122847/
https://www.ncbi.nlm.nih.gov/pubmed/37155496
http://dx.doi.org/10.2147/COPD.S405498

Ejemplares similares